The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics

E Pajarillo, A Rizor, J Lee, M Aschner, E Lee - Neuropharmacology, 2019 - Elsevier
Glutamate is the primary excitatory neurotransmitter in the central nervous system (CNS)
which initiates rapid signal transmission in the synapse before its re-uptake into the …

[HTML][HTML] The two sides of YY1 in cancer: a friend and a foe

S Sarvagalla, SP Kolapalli, S Vallabhapurapu - Frontiers in oncology, 2019 - frontiersin.org
Yin Yang 1 (YY1), a dual function transcription factor, is known to regulate transcriptional
activation and repression of many genes associated with multiple cellular processes …

A de novo paradigm for mental retardation

LELM Vissers, J de Ligt, C Gilissen, I Janssen… - Nature …, 2010 - nature.com
The per-generation mutation rate in humans is high. De novo mutations may compensate for
allele loss due to severely reduced fecundity in common neurodevelopmental and …

[HTML][HTML] The molecular basis of MeCP2 function in the brain

R Tillotson, A Bird - Journal of molecular biology, 2020 - Elsevier
MeCP2 is a reader of the DNA methylome that occupies a large proportion of the genome
due to its high abundance and the frequency of its target sites. It has been the subject of …

The role of MeCP2 in the brain

J Guy, H Cheval, J Selfridge… - Annual review of cell and …, 2011 - annualreviews.org
Methyl-CpG binding protein 2 (MeCP2) was first identified in 1992 as a protein that binds
specifically to methylated DNA. Mutations in the MECP2 gene were later found to be the …

Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome

D Valenti, L de Bari, B De Filippis… - Neuroscience & …, 2014 - Elsevier
Clinical manifestations typical of mitochondrial diseases are often present in various genetic
syndromes associated with intellectual disability, a condition leading to deficit in cognitive …

[HTML][HTML] Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism

A Chevrollier, D Loiseau, P Reynier… - Biochimica et Biophysica …, 2011 - Elsevier
Adenine nucleotide translocase (ANT), a mitochondrial protein that facilitates the exchange
of ADP and ATP across the mitochondrial inner membrane, plays an essential role in …

[HTML][HTML] Mitochondrial dysfunction in the pathogenesis of Rett syndrome: implications for mitochondria-targeted therapies

N Shulyakova, AC Andreazza, LR Mills… - Frontiers in cellular …, 2017 - frontiersin.org
First described over 50 years ago, Rett syndrome (RTT) is a neurodevelopmental disorder
caused primarily by mutations of the X-linked MECP2 gene. RTT affects predominantly …

The mitochondrial ADP/ATP carrier (SLC25 family): pathological implications of its dysfunction

B Clémençon, M Babot, V Trézéguet - Molecular aspects of medicine, 2013 - Elsevier
In aerobic eukaryotic cells, the high energy metabolite ATP is generated mainly within the
mitochondria following the process of oxidative phosphorylation. The mitochondrial ATP is …

Mitochondrial dysfunction: a common denominator in neurodevelopmental disorders?

XR Ortiz-González - Developmental neuroscience, 2021 - karger.com
Mitochondria, the organelles classically seen as the powerhouse of the cell, are increasingly
associated with a wide variety of neurodevelopmental disorders. Although individually rare …